Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthias Preusser

Showing results (131-140 of 525) with videos related to

Pageof 53
Sort By:
Neuro-Oncology Practice|January 8, 2025
Who will benefit from vorasidenib? Review of data from the literature and open questionsAmélie Darlix, Matthias Preusser, Shawn L Hervey-Jumper, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|August 17, 2015
Expression profiling of angiogenesis-related genes in brain metastases of lung cancer and melanomaAysegül Ilhan-Mutlu, Christian Siehs, Anna Sophie Berghoff, et al.
Clinical Neuropathology|August 22, 2015
Clinical Neuropathology practice guide 5-2015: MGMT methylation pyrosequencing in glioblastoma: unresolved issues and open questionsMichal Bienkowski, Anna S Berghoff, Christine Marosi, et al.
Journal of Neuro-Oncology|February 20, 2013
Comparison of microRNA expression levels between initial and recurrent glioblastoma specimensAysegül Ilhan-Mutlu, Adelheid Wöhrer, Anna Sophie Berghoff, et al.
Cancer Investigation|June 5, 2014
Downregulation of CIC does not associate with overexpression of ETV1 or MAP kinase pathway activation in gastrointestinal stromal tumorsSebastian F Schoppmann, Gerda Ricken, Aysegül Ilhan-Mutlu, et al.
Cancer Biology & Therapy|August 19, 2008
Everolimus (RAD001) and anti-angiogenic cyclophosphamide show long-term control of gastric cancer growth in vivoDaniel Cejka, Matthias Preusser, Adelheid Woehrer, et al.
Histopathology|April 8, 2015
Evaluation of tyrosine kinase receptors in brain metastases of clear cell renal cell carcinoma reveals cMet as a negative prognostic factorAna-Iris Schiefer, Ildiko Mesteri, Anna S Berghoff, et al.
Research and Practice in Thrombosis and Haemostasis|June 17, 2025
Clonal hematopoiesis in patients with cancer and its association with risk of thrombosis and prognosis of diseaseCornelia Englisch, Roland Jäger, Jasmina Gassner, et al.
Haematologica|October 12, 2023
Tissue factor pathway inhibitor is associated with risk of venous thromboembolism and all-cause mortality in patients with cancerCornelia Englisch, Florian Moik, Johannes Thaler, et al.
ESMO Open|February 2, 2018
Recent advances in the biology and treatment of brain metastases of non-small cell lung cancer: summary of a multidisciplinary roundtable discussionMatthias Preusser, Frank Winkler, Manuel Valiente, et al.
Pageof 53

Showing results (131-140 of 525) with videos related to

Sort By:
Pageof 53
Neuro-Oncology Practice|January 8, 2025
Who will benefit from vorasidenib? Review of data from the literature and open questionsAmélie Darlix, Matthias Preusser, Shawn L Hervey-Jumper, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|August 17, 2015
Expression profiling of angiogenesis-related genes in brain metastases of lung cancer and melanomaAysegül Ilhan-Mutlu, Christian Siehs, Anna Sophie Berghoff, et al.
Clinical Neuropathology|August 22, 2015
Clinical Neuropathology practice guide 5-2015: MGMT methylation pyrosequencing in glioblastoma: unresolved issues and open questionsMichal Bienkowski, Anna S Berghoff, Christine Marosi, et al.
Journal of Neuro-Oncology|February 20, 2013
Comparison of microRNA expression levels between initial and recurrent glioblastoma specimensAysegül Ilhan-Mutlu, Adelheid Wöhrer, Anna Sophie Berghoff, et al.
Cancer Investigation|June 5, 2014
Downregulation of CIC does not associate with overexpression of ETV1 or MAP kinase pathway activation in gastrointestinal stromal tumorsSebastian F Schoppmann, Gerda Ricken, Aysegül Ilhan-Mutlu, et al.
Cancer Biology & Therapy|August 19, 2008
Everolimus (RAD001) and anti-angiogenic cyclophosphamide show long-term control of gastric cancer growth in vivoDaniel Cejka, Matthias Preusser, Adelheid Woehrer, et al.
Histopathology|April 8, 2015
Evaluation of tyrosine kinase receptors in brain metastases of clear cell renal cell carcinoma reveals cMet as a negative prognostic factorAna-Iris Schiefer, Ildiko Mesteri, Anna S Berghoff, et al.
Research and Practice in Thrombosis and Haemostasis|June 17, 2025
Clonal hematopoiesis in patients with cancer and its association with risk of thrombosis and prognosis of diseaseCornelia Englisch, Roland Jäger, Jasmina Gassner, et al.
Haematologica|October 12, 2023
Tissue factor pathway inhibitor is associated with risk of venous thromboembolism and all-cause mortality in patients with cancerCornelia Englisch, Florian Moik, Johannes Thaler, et al.
ESMO Open|February 2, 2018
Recent advances in the biology and treatment of brain metastases of non-small cell lung cancer: summary of a multidisciplinary roundtable discussionMatthias Preusser, Frank Winkler, Manuel Valiente, et al.
Pageof 53